Ocumension Therapeutics (1477.HK)
HKD 4.56
(-1.72%)
HKD 4.56
(-1.72%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 246.36 Million | 158.95 Million | 56.14 Million | 13.09 Million | 190 Thousand | - |
| Cost of Revenue | 102 Million | 56.04 Million | 19.21 Million | 1.72 Million | 10 Thousand | - |
| Gross Profit | 144.36 Million | 102.91 Million | 36.93 Million | 11.37 Million | 180 Thousand | - |
| Operating Expenses | 144.36 Million | 551.14 Million | 422.47 Million | 499.19 Million | 159.12 Million | 49.44 Million |
| Selling, General and Administrative Expenses | 279 Million | 373.78 Million | 253.8 Million | 324.66 Million | 9.71 Million | 3.57 Million |
| Research and Development Expenses | 123.76 Million | 184.3 Million | 169.05 Million | 179.55 Million | 99.46 Million | 40.67 Million |
| Other Expenses | - | -6.95 Million | -382 Thousand | -5.02 Million | 49.94 Million | -158.73 Million |
| Cost and Expenses | 647.7 Million | 607.18 Million | 441.69 Million | 500.92 Million | 159.13 Million | 49.44 Million |
| Operating Income | -402.14 Million | -397.23 Million | -385.2 Million | -2.27 Billion | -1.33 Billion | -49.44 Million |
| Interest Expense | 1.32 Million | 1.79 Million | 567 Thousand | 59 Thousand | 63 Thousand | 5000.00 |
| Income Tax Expense | 307 Thousand | 414 Thousand | -125.21 Million | -7.57 Million | -23.88 Million | -159.95 Million |
| Earnings before Tax | -379.48 Million | -402.22 Million | -259.99 Million | -2.26 Billion | -1.32 Billion | -209.4 Million |
| Net Income | -379.78 Million | -402.64 Million | -134.78 Million | -2.25 Billion | -1.3 Billion | -207.6 Million |
| Earnings Per Share Basic | -0.59 | -0.64 | -0.22 | -7.47 | -2.26 | -0.36 |
| Earnings Per Share Diluted | -0.59 | -0.64 | -0.22 | -7.47 | -2.26 | -0.36 |
| Weighted Average Shares Outstanding | 649.18 Million | 632.53 Million | 607.14 Million | 302.34 Million | 575.25 Million | 575.25 Million |
| Weighted Average Shares Outstanding (Diluted) | 649.18 Million | 632.53 Million | 607.14 Million | 302.34 Million | 575.25 Million | 575.25 Million |
| Gross Margin | 0.59 | 0.65 | 0.66 | 0.87 | 0.95 | - |
| EBIT Margin | -1.30 | -2.24 | -6.61 | -173.17 | -7026.26 | - |
| Profit Margin | -1.54 | -2.53 | -2.40 | -172.37 | -6850.50 | - |
| EBITDA | -320.61 Million | -359.97 Million | -371.3 Million | -2.26 Billion | -1.32 Billion | -59.31 Million |
| Earnings Before Tax Margin | -1.63 | -2.50 | -6.86 | -173.52 | -7032.62 | - |
| Breakdown | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 FY |
|---|---|---|---|---|---|---|
| Revenue | 246.36 Million | 71.33 Million | 71.33 Million | 51.84 Million | 51.84 Million | 158.95 Million |
| Cost of Revenue | 102 Million | 30.5 Million | 30.5 Million | 20.49 Million | 20.49 Million | 56.04 Million |
| Gross Profit | 144.36 Million | 40.82 Million | 40.82 Million | 31.35 Million | 31.35 Million | 102.91 Million |
| Operating Expenses | 545.7 Million | 130.69 Million | 130.69 Million | 141.52 Million | 141.52 Million | 551.14 Million |
| Selling, General and Administrative Expenses | - | 104.12 Million | 104.12 Million | 107.24 Million | 107.24 Million | - |
| Research and Development Expenses | - | 25.33 Million | 25.33 Million | 36.54 Million | 36.54 Million | - |
| Other Expenses | -3.81 Million | - | - | - | - | -6.95 Million |
| Cost and Expenses | 647.7 Million | 161.2 Million | 161.2 Million | 162.02 Million | 162.02 Million | 607.18 Million |
| Operating Income | -402.14 Million | -88.63 Million | -88.63 Million | -112.43 Million | -112.43 Million | -397.23 Million |
| Interest Expense | 1.32 Million | - | - | 722.67 Thousand | - | 1.79 Million |
| Income Tax Expense | 307 Thousand | 84 Thousand | 84 Thousand | 69.5 Thousand | 69.5 Thousand | 414 Thousand |
| Earnings before Tax | -379.48 Million | -85.6 Million | -85.6 Million | -104.13 Million | -104.13 Million | -402.22 Million |
| Net Income | -379.78 Million | -85.69 Million | -85.69 Million | -104.2 Million | -104.2 Million | -402.64 Million |
| Earnings Per Share Basic | - | -0.13 | -0.13 | -0.16 | -0.16 | - |
| Earnings Per Share Diluted | - | -0.13 | -0.13 | -0.16 | -0.16 | - |
| Weighted Average Shares Outstanding | 643.7 Million | 652.1 Million | 652.1 Million | 646.27 Million | 646.27 Million | 632.53 Million |
| Weighted Average Shares Outstanding (Diluted) | 643.7 Million | 652.1 Million | 652.1 Million | 646.26 Million | 646.26 Million | 632.53 Million |
| Gross Margin | 0.59 | 0.57 | 0.57 | 0.60 | 0.60 | 0.65 |
| EBIT Margin | - | -1.08 | -1.08 | -1.94 | -1.94 | - |
| Profit Margin | -1.54 | -1.20 | -1.20 | -2.01 | -2.01 | -2.53 |
| EBITDA | - | -77.15 Million | -77.15 Million | -100.72 Million | -100.72 Million | - |
| Earnings Before Tax Margin | -1.63 | -1.24 | -1.24 | -2.17 | -2.17 | -2.50 |
BSDGY
CFEB
ALINV
IEP
BHP
031330